SERA PROGNOSTICS, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
SERA PROGNOSTICS, INC. (SERA) had Debt Securities, Available-for-sale, Unrealized Loss Position of $41.50 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-12
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $41.50M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $36.86M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $13.36M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $18.07M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $41.50M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $36.86M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $13.36M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $18.07M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $26.95M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $37.10M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $11.33M 10-K · filed 2026-03-18 |
| 2024-09-30 | $20.37M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $66.73M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $60.76M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $46.33M 10-K · filed 2025-03-19 |
| 2023-09-30 | $79.85M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $90.26M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $77.35M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $99.06M 10-K · filed 2024-03-20 |
| 2022-09-30 | $108.26M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |